Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu • (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.

This mass spectrometry method can locate where molecular changes occur in a thin slice of tissue, and it has broad applicability to biomedical research.
Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
Greater efficiency is a must for future clinical use of these cells in regenerative medicine, drug screening and disease study.
These awards from the National Institute of Environmental Health Sciences recognize exceptional early-career scientists.
This protective effect on cardiotoxicity could benefit cancer chemotherapy recipients and heart failure patients.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
The properties of cubic or spherical shape and solid or elastic stiffness affect the fates of polymer microcapsules meant to carry chemotherapy to a tumor.
One major goal is the discovery of new genotype/phenotype correlations — how a particular mutation indicates that some symptoms in patients are unlikely to develop with age.
Page 34 of 39